Skip to main content
. 2017 Mar 10;8(17):28431–28441. doi: 10.18632/oncotarget.16085

Figure 1. Cell viability and morphological changes in BMSCs after neural induction and wogonin treatment.

Figure 1

(A) Effects of wogonin on BMSCs viability. Cell activity decreased by 18%-29% in BMSCs treated with 6-15 μg/ml of wogonin (*p < 0.05). (B) BMSCs viability after 24h of neural induction (#p < 0.05, neural induction and wogonin versus control group; **p < 0.01, *p < 0.05, wogonin versus standard neural induction group). (C) BMSCs viability changes after 48h of induction. (D) Morphological changes in BMSCs 14 days after induction. Scale bar = 25 μm.